Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis

British Journal of Pharmacology

Volumn 107, Issue 2, 1992, Pages 356-360

  Griesbacher, T ^a   Lembeck, F ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bradykinin antagonists; caerulein; HOE 140; hypotension; pancreatitis (experimental); plasma protein extravasation; serum amylase; serum lipase

Indexed keywords

AMYLASE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ DERIVATIVE; CERULETIDE; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 5,8 [3 (2 THIENYL)ALANINE] 7 DEXTRO PHENYLALANINE]; ICATIBANT; KALLIKREIN; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; EDEMA; ENZYME ACTIVITY; FEMALE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE DISEASE; AMYLASES; ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; BRADYKININ; CAERULEIN; FEMALE; KALLIKREINS; LIPASE; OLIGOPEPTIDES; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0026667830     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1992.tb12751.x     Document Type: Article

References (30)

1. Experimental models and concepts in acute pancreatitis
2. Kinin antagonist does not protect against the hypotensive response to endotoxin, anaphylaxis or acute pancreatitis
3. Objectification of the severity of acute pancreatitis
4. Demonstration and characterization of the hemoconcentrating effect of ascitic fluid that accumulates during hemorrhagic pancreatitis
5. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin
6. Discovery and role of T‐kininogen
7. 2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit
8. Bradykinin antagonists with high potency and long duration of action in vivo
9. Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation
10. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies
11. Hypocalcaemia of acute pancreatitis: the effect of hypoalbuminaemia
12. Actions of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear
13. Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells
14. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations
15. New, long‐acting, potent bradykinin antagonists
16. Visceral pain: a review of experimental studies
17. Hemorrhagic pancreatitis
18. The binding of T‐1824 and structurally related diazo dyes by plasma proteins
19. Studies on the plasma kallikrein‐kinin system in peritoneal exudate and plasma during experimental acute pancreatitis in pigs
20. Role of bradykinin in the development of acute pancreatitis
21. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues
22. Hemodynamic change and bradykinin levels in plasma and lymph during experimental actute pancreatitis in dogs
23. Sensory substance P innervation of the stomach and pancreas; demonstration of capsaicin‐sensitive sensory neurons in the rat by combined immunohistochemistry and retrograde tracing
24. Effects of the cholecystokinin receptor antagonist L‐364,718 on experimental pancreatitis in mice
25. Discovery of the most important kallikreins and kallikrein inhibitors
26. Caerulein‐induced acute pancreatitis in rats: changes in glycoprotein‐compostion of subcellular membrane systems in acinar cells
27. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies
28. Cholecystokinin antagonists